Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction - Gislason, GH; Jacobsen, S; Rasmussen, JN (Circulation, 2006)